Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays

Proteomics

Volumn 8, Issue 10, 2008, Pages 1980-1986

  Schnack, Cathrin ^a   Hengerer, Bastian ^a   Gillardon, Frank ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Kinase; Protein array; Selectivity screen; Substrate screen

Indexed keywords

CYCLIN DEPENDENT KINASE 5; CYCLIN DEPENDENT KINASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; INDOLINONE A; PHOSPHOPROTEIN PHOSPHATASE 1;

ANIMAL CELL; ARTICLE; DRUG SELECTIVITY; ENZYME SUBSTRATE; IN VITRO STUDY; MICROARRAY ANALYSIS; NEUROPROTECTION; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; RAT;

CYCLIN-DEPENDENT KINASE 5; HUMANS; INDOLES; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTEIN PHOSPHATASE 1; SUBSTRATE SPECIFICITY;

EID: 44649091314     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701063     Document Type: Article

References (43)

1. Cheung, Z. H., Ip, N. Y., Cdk5: Mediator of neuronal death and survival. Neurosci. Lett. 2004, 361, 47-51.
2. Tanaka, T., Serneo, F. F., Tseng, H.-C., Kulkarni, A. B. et al., Cdk5 phosphorylation of doublecortin Ser297 regulates its effect on neuronal migration. Neuron 2004, 41, 215-227.
3. Lew, J., Beaudette, K., Litwin, C. M. E., Wang, J. H., Purification and characterization of a novel proline-directed protein kinase from bovine brain. J. Biol. Chem. 1992, 276, 13383-13390.
4. Ko, J., Humbert, S., Bronson, R. T., Takahashi, S. et al., p35 and p39 are essential for cyclin-dependent kinase 5 function during development. J. Neurosci. 2001, 21, 6758-6771.
5. Dhavan, R., Tsai, L.-H., A decade of Cdk5. Nat. Rev. Mol. Cell. Biol. 2001, 2, 749-759.
6. Shelton, S. B., Johnson, G. V. W., Cyclin-dependent kinase-5 in neurodegeneration. J. Neurochem. 2004, 88, 1313-1326.
7. Patrick, G. N., Zuckerberg, L., Nikolic, M., de la Monte, S. et al., Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999, 402, 615-622.
8. Tsai, L.-H., Takahashi, T., Caviness, V. S., Jr., Harlow, E., Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 1993, 119, 1029-1040.
9. Grant, P., Sharma, P., Pant, H. C., Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism. FEBS J. 2001, 268, 1534-1546.
10. Gong, X., Tang, X., Wiedmann, M., Wang, X. et al., Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003, 38, 33-46.
11. Zhang, J., Krishnamurthy, P. K., Johnson, G. V., Cdk5 phosphorylates p53 and regulates its activity. J. Neurochem. 2002, 81, 307-313.
12. Johnson, S. A., Hunter, T., Kinomics: Methods for deciperhing the kinome. Nat. Methods 2005, 2, 17-25.
13. Cohen, P., Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 2002, 1, 309-315.
14. Dancey, J., Sausville, E. A., Issues and progress with protein kinase inhibitors for cancer treatment. Nature 2003, 2, 296-313.
15. O'Hare, M., Wang, F., Pakr, D. S., Cyclin-dependent kinases as potential targets to improve stroke outcome. Pharmacol. Ther. 2002, 93, 135-143.
16. Weishaupt, J. H., Kussmaul, L., Grötsch, P., Heckel, A. et al., Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction. Mol. Cell. Neurosci. 2003, 24, 489-502.
17. Lin, H., Juang, J.-L., Wang, P. S., Involvment of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. J. Biol. Chem. 2004, 79, 29302-29307.
18. Manning, G., Whyte, D. B., Maritinez, R., Hunter, T., Sudarsanam, S., The protein kinase complement of the human genome. Science 2002, 298, 1912-934.
19. Eto, M., Bock, R., Brautigan, D. L., Linden, D. J., Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor. Neuron 2002, 36, 1145-1158.
20. Becker, W., Weber, Y., Wetzel, K., Eirmbter, K. et al., Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinase, a novel family of dual specificity protein kinases. J. Biol. Chem. 1998, 273, 25893-25902.
21. Morabito, M. A., Sheng, M., Tsai, L.-H., Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the post-synaptic density protein PSD-95 in neurons. J. Neurosci. 2004, 24, 865-876.
22. Moy, L. Y., Tsai, L.-H., Cyclin-dependent kinase 5 phoshorylates serine 31 of tyrosine hydroxylase and regulates its stability. J. Biol. Chem. 2004, 297, 54487-54493.
23. Nikolic, M., Chou, M. M., Lu, W., Mayer, B. J., Tsai, L.-H., The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 1998, 395, 194-198.
24. Keshvara, L., Magdaleno, S., Benhayon, D., Curran, T., Cyclin-dependent kinase 5 phosphorylates disabled 1 independently of reelin signaling. J. Neurosci. 2002, 22, 4869-4877.
25. Niethammer, M., Smith, D. S., Ayala, R., Peng, J. et al., NUDEL is a novel Cdk5 substrate that associates with LIS1 and cytoplasmic dynein. Neuron 2000, 28, 697-711.
26. Sasaki, S., Shionoya, A., Ishida, M., Gambello, M. J. et al., A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron 2000, 28, 681-696.
27. Hayashi, K., Pan, Y., Oshima, T., Kansy, J. W. et al., Phoshorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain. J. Neurochem. 2006, 99, 237-250.
28. Eto, M., Ohmori, T., Suzuki, M., Furuya, K., Morita, F., A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J. Biochem. 1995, 118, 1104-1107.
29. Dubois, T., Howell, S., Zemlickova, E., Learmonth, M., Cronshaw, A., Novel in vitro and in vivo phosphorylation sites on protein phosphatase 1 inhibitor CPI-17. Biochem. Biophys. Res. Commun. 2003, 302, 186-192.
30. Hawasaki, A. H., Bibb, J. A., Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol. J. 2007, 2, 941-948.
31. Zelda, H. C., Ip, N. Y., The role of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol. J. 2007, 2, 949-957.
32. Cohen, P., The structure and regulation of protein phosphatase. Annu. Rev. Biochem. 1989, 58, 453-508.
33. Lee, E. Y. C., Zhao, L. Z. S., Wei, Q., Zhang, J. et al., Phosphorylase phosphatase: New horizons for an old enzyme. Front. Biosci. 1999, 4, 270-285.
34. Li, T., Chalifour, L. E., Paudel, H. K., Phosphorylation of protein phosphatase 1 by cyclin- dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation. J. Biol. Chem. 2006, 282, 6619-6628.
35. Morfini, G., Szebenyi, G., Brown, H., Pant, H. et al., A novel Cdk5-dependent pathway for regulating GSK3 activity and kinesin driven motility in neurons. EMBO J. 2004, 2, 2235-2245.
36. Avraham, E., Rott, R., Liani, E., Szargel, R., Engelender, S., Phosphorylation of parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J. Biol. Chem. 2007, 282, 12842-12850.
37. Osuga, H., Osuga, S., Wang, F., Fetni, R. et al., Cyclin-dependent kinases as a therapeutic target for stroke. Proc. Natl. Acad. Sci. USA 2000, 97, 10254-10259.
38. Gillardon, F., Steinlein, P., Bürger, E., Hildebrandt, T., Gerner, C., Phosphoproteome and transcriptome analysis of the neuronal response to a CDK5 inhibitor. Proteomics 2005, 5, 1299-1307.
39. Zelenka, P. S., Smith, J., Therapeutic potential of Cdk5 inhibitors to promote corneal epithelial wound healing. Expert Opin. Ther. Pat. 2005, 15, 875-887.
40. Sridhar, J., Akula, N., Pattabiraman, N., Selectivity and potency of cyclin-dependent kinase inhibitors. AAPS J. 2006, 8, E204-E221.
41. Force, T., Kuida, K., Namchuk, M., Inhibitors of protein kinase signaling pathway. Circulation 2004, 109, 1196-1205.
42. Blackburn, J. M., Hart, D. J., Fabrication of protein function microarrays for systems-orientated proteomic analysis. Methods Mol. Biol. 2005, 310, 197-216.
43. Boutell, J. M., Hart, D. J., Godber, B. L. J., Kozlowski, R. Z., Blackburn, J. M., Functional protein microarrays for parallel characterisation of p53 mutants. Proteomics 2004, 4, 1950-1958.